These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11347055)

  • 1. [Lipid metabolism and obstructive liver disease].
    Satoh H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():186-9. PubMed ID: 11347055
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid normalization of severe hypercholesterolemia mediated by lipoprotein X after liver transplantation in a patient with cholestasis - a case report.
    Jankowski K; Wyzgał A; Wierzbicka A; Tronina O; Durlik M; Pruszczyk P
    Acta Biochim Pol; 2015; 62(3):621-3. PubMed ID: 26317127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine alterations in experimental cholestasis and its subsequent cirrhosis.
    Ebrahimkhani MR; Sadeghipour H; Dehghani M; Kiani S; Payabvash S; Riazi K; Honar H; Pasalar P; Mirazi N; Amanlou M; Farsam H; Dehpour AR
    Life Sci; 2005 Apr; 76(21):2497-512. PubMed ID: 15763080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liver damages and lipid metabolism. II. Biosynthesis of cholesterol, phospholipids and glycerides in the liver in experimental cholestasis in the rat].
    Kattermann R; Reimold WV
    Acta Hepatosplenol; 1970; 17(2):75-84. PubMed ID: 5524292
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lipid metabolism].
    Iriyama K
    Nihon Rinsho; 1991 Nov; 49 Suppl():289-94. PubMed ID: 1798109
    [No Abstract]   [Full Text] [Related]  

  • 6. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents.
    Boyer JL; Trauner M; Mennone A; Soroka CJ; Cai SY; Moustafa T; Zollner G; Lee JY; Ballatori N
    Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1124-30. PubMed ID: 16423920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protein-copper complex in primary biliary cirrhosis and other chronic diffuse diseases of the liver].
    Loginov AS; Aruin LI; Shepeleva SD
    Arkh Patol; 1980; 42(4):50-5. PubMed ID: 7396755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholestatic lipoproteins--their pathogenesis and significance.
    Sabesin SM
    Gastroenterology; 1982 Sep; 83(3):704-9. PubMed ID: 7095374
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipid metabolism disorders in primary biliary cirrhosis (PBC)].
    Schimming W; Schentke KU; Gehrich S; Jaross W; Kobe E
    Gastroenterol J; 1991; 51(1):18-21. PubMed ID: 1910490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: a systematic review.
    Sorokin A; Brown JL; Thompson PD
    Atherosclerosis; 2007 Oct; 194(2):293-9. PubMed ID: 17240380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatobiliary regulation of lipid metabolism].
    Vecchi GP; Salvioli GF; Salati R; Spögler W
    Schweiz Med Wochenschr; 1970 Oct; 100(40):1694-8. PubMed ID: 5524981
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chylomicron metabolism].
    Damião AO; Sipahi e AM; Quintão EC
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(5):267-70. PubMed ID: 2700110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of gallbladder bile lithogenicity in patients with primary biliary cirrhosis.
    Fracchia M; Jazrawi RP; Galatola G
    Ital J Gastroenterol; 1996 Jun; 28(5):255-60. PubMed ID: 8842843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthesis and metabolism of bile acids in man.
    Björkhem I; Danielsson H
    Prog Liver Dis; 1976; 5():215-31. PubMed ID: 818678
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia.
    Sörös P; Böttcher J; Maschek H; Selberg O; Müller MJ
    Hepatology; 1998 Nov; 28(5):1199-205. PubMed ID: 9794902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chylomicron metabolism in experimental cholestasis].
    Damião AO; Sipahi AM; Quintão EC
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(5):207-10. PubMed ID: 2636994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in the lipid profile in chronic hepatopathies].
    Perales J; Angel Lasunción M; Cano A; Martín-Scapa MA; Matíes M; Herrera E
    Med Clin (Barc); 1994 Mar; 102(10):364-8. PubMed ID: 8182981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis of hyperlipoproteinemias].
    Müller G
    Z Gesamte Inn Med; 1974 Jun; 29(12):469-76. PubMed ID: 4368206
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental study on lipid and bilirubin metabolism after biliary drainage for obstructive jaundice.
    Tsuchiya A; Haga S; Watanabe O; Kumazawa K; Kajiwara T
    J Surg Res; 2001 Mar; 96(1):50-5. PubMed ID: 11180996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surrogate markers of cholesterol metabolism in children with native liver after successful portoenterostomy for biliary atresia.
    Pakarinen MP; Lampela H; Gylling H; Miettinen TA; Koivusalo AI; Nissinen MJ
    J Pediatr Surg; 2010 Aug; 45(8):1659-64. PubMed ID: 20713216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.